AgeX Therapeutics Cash from Operations (TTM) Analysis

AgeX Therapeutics Inc (DELISTED) (AGE:DL)

11.10 -1.50 (-11.90%) USD | NYAM | Mar 26, 16:00

12.18 +1.08 (+9.73%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2023	-7.069M
June 30, 2023	-6.441M
March 31, 2023	-6.168M
December 31, 2022	-5.939M
September 30, 2022	-6.265M
June 30, 2022	-6.913M
March 31, 2022	-6.861M
December 31, 2021	-7.855M
September 30, 2021	-7.828M
June 30, 2021	-7.833M

Date	Value
March 31, 2021	-8.383M
December 31, 2020	-7.817M
September 30, 2020	-8.608M
June 30, 2020	-9.091M
March 31, 2020	-9.606M
December 31, 2019	-10.16M
September 30, 2019	-9.795M
June 30, 2019	-9.206M
March 31, 2019	-8.608M
December 31, 2018	-7.995M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-10.16M

Minimum

Dec 2019

-5.939M

Maximum

Dec 2022

-7.880M

Average

-7.830M

Median

Cash from Operations (TTM) Benchmarks